Consistent improvement with eculizumab across muscle groups in myasthenia gravis.
Renato MantegazzaFanny L O'BrienMarcus YountzJames F Howardnull nullPublished in: Annals of clinical and translational neurology (2020)
Eculizumab treatment elicits rapid and sustained improvements in muscle strength across ocular, bulbar, respiratory, and limb/gross motor muscle groups and in associated daily activities in patients with refractory anti-acetylcholine receptor antibody-positive generalized myasthenia gravis.